Clinical and economic implications of the use of nanoparticle paclitaxel (Nanoxel) in India. [electronic resource]
Producer: 20140317Description: v6-12 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents
- Cost-Benefit Analysis
- Drug-Related Side Effects and Adverse Reactions -- classification
- Female
- Humans
- India
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Nanoparticles -- adverse effects
- Neoplasms -- drug therapy
- Paclitaxel -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.